NUBAD, LLC was founded by Dr. Dev P. Arya in 2009 to commercialize DNA and RNA targeted technologies and drugs. NUBAD, LLC opened its labs in 2011 at Greenville Hospital System ITOR Facility (GHS-ITOR) located in Greenville, South Carolina, in a private sector innovation relationship platform.
NUBAD’s goal is to be a leading facilitator in the targeting of nucleic acid based drugs. The Company develops novel probes, assays and small molecule therapeutics targeting RNA and DNA structures identified as targets in human disease. As new genomic targets are identified, NUBAD’s technologies will assist discovery of DNA and RNA targeted small molecule drugs.